+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paratek Pharmaceuticals - logo

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.

From
Plague - Pipeline Insight, 2024 - Product Thumbnail Image

Plague - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
mTOR Inhibitors Global Market Report 2024 - Product Thumbnail Image

mTOR Inhibitors Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Anthrax - Pipeline Insight, 2024 - Product Thumbnail Image

Anthrax - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
From
From
Paratek Pharmaceuticals Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

Paratek Pharmaceuticals Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2024
  • 33 Pages
From
Loading Indicator